Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. - Wikidata - thesis-toulmin - TriplyDB

Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions.

Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions.

http://www.wikidata.org/entity/Q37333543

about

Molecular mechanisms of diabetic kidney disease Protocol for systematic review of evidence on the determinants and influence of early glycaemic control in childhood-onset type 1 diabetes Toward beta cell replacement for diabetes Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases Predictors of glycemic control in the first year of diagnosis of childhood onset type 1 diabetes: A systematic review of quantitative evidence Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative Psycho-educational interventions for children and young people with Type 1 Diabetes in the UK: How effective are they? A systematic review and meta-analysis.The effectiveness and durability of an early insulin pump therapy in children and adolescents with type 1 diabetes mellitus Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study Do Cinnamon Supplements Have a Role in Glycemic Control in Type 2 Diabetes? A Narrative Review Use of an oral stable isotope label to confirm variation in red blood cell mean age that influences HbA1c interpretation.Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes.Cardiac autoimmunity as a novel biomarker, mediator, and therapeutic target of heart disease in type 1 diabetes.Symptoms of Eating Disorders and Depression in Emerging Adults with Early-Onset, Long-Duration Type 1 Diabetes and Their Association with Metabolic Control.Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.Low socioeconomic status is associated with adverse events in children and teens on insulin pumps under a universal access program: a population-based cohort study.Associations between metabolic dysregulation and circulating biomarkers of fibrosis: the Cardiovascular Health Study.Hemoglobin a1c in the ESRD population: status report.Advances in pathology of diabetes from pancreatic islets to neuropathy--a tribute to Paul Langerhans.Projected long-term outcomes in patients with type 1 diabetes treated with fast-acting insulin aspart vs conventional insulin aspart in the UK setting.Identifying Key Intervention Opportunities During a Pregnancy Complicated by Diabetes: a Review of Acute Complications of Diabetes During Pregnancy.Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications.The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes.Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative.Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.Association of Cardiovascular Risk Factors and Myocardial Fibrosis With Early Cardiac Dysfunction in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.Mortality in Type 1 Diabetes in the DCCT/EDIC Versus the General Population.Technology Use in Transition-Age Patients With Type 1 Diabetes: Reality and Promises.Type 1 diabetes during adolescence: International comparison between Germany, Austria, and Sweden.Long-term Effect of Losartan on Kidney Disease in American Indians With Type 2 Diabetes: A Follow-up Analysis of a Randomized Clinical Trial.Compound Danshen Dripping Pill for Treating Nonproliferative Diabetic Retinopathy: A Meta-Analysis of 13 Randomized Controlled Trials.Continuous electrical current and zinc sulphate administered by transdermal iontophoresis improves skin healing in diabetic rats induced by alloxan: morphological and ultrastructural analysis.A Novel Type 2 Diabetes Mouse Model of Combined Diabetic Kidney Disease and Atherosclerosis.Avocado oil induces long-term alleviation of oxidative damage in kidney mitochondria from type 2 diabetic rats by improving glutathione status.Understanding the impact of hypoglycemia on the cardiovascular system.Recent advances in the management and understanding of diabetic retinopathy.

P2860

Q27003963-655744F7-5749-48DF-8E13-F637643A6E2B Q28082045-3404215A-4F74-401F-8F81-558EB384C3DC Q28083650-A06CB5C5-7904-4F1A-9126-EE89D1AA9D91 Q28085428-035150B3-3B33-4AD8-88DA-DE8A285147DB Q28354033-EB969C83-9D78-435C-BFC7-4505AAF3AB1D Q29994508-F73D6431-C2D6-4AAD-A7EF-E8910FB49FA6 Q33789640-845B31DA-3B4A-401D-80C2-8209676417B5 Q33859884-B613AF89-055E-4C54-85D9-D8356A375ED3 Q34360873-E88D7C0E-E32E-4A98-ADDE-A04AB88FEA54 Q34433105-C98D209B-4432-4E90-A347-34FF26D96BD9 Q34540095-12EFFF9A-439E-4990-B362-269ED04CB0D9 Q34772031-9DFAEB11-E68C-430A-80EA-8642AB74FD0E Q35004314-17E743E6-77BB-4354-A834-C4254C5D1059 Q35012749-1B1F6D6B-25B9-4D2E-9406-73B8CE369F40 Q35044151-4F18EADA-78F4-447B-8522-845EBC78D91B Q35225450-DB5287F1-AFBD-4099-95EC-C3FDA6C16044 Q35677081-3609476B-FF81-4A42-AD5A-63196C057308 Q36079520-20FFBE94-4236-497C-8756-9BEF4822BDDB Q36166755-B9864AB6-413C-487B-BF23-48079728A060 Q37063696-0CFEE4A2-3060-4C3E-A9CB-3F5D63865E45 Q37082373-21161217-ED28-4A51-AF4E-4058A5400EDF Q38231450-57F9E1E3-FB02-40E7-A955-BE848BA11533 Q38364481-D248327D-D5C1-453C-895E-4AECE292DF26 Q38675810-0ECFB721-D34F-4A08-AD0F-3E82CF76A779 Q38711611-2ADCC86C-E01A-4AD1-9C62-EEDA7BB980C8 Q38843881-9AFEC88E-97C5-4F1E-84A9-D6A9A4DFFF8A Q38848764-A8EC6371-71B8-467D-A521-0A405E510745 Q39115570-81FD8501-9E94-4A17-B654-4806D533899B Q40236321-95200F46-B4CE-441D-8BED-4AC7B4666ADE Q40420450-0E95A990-AB35-4174-8131-6DDD8CC0995F Q40653191-1AFEDD70-E1C9-47D3-816D-046EB4451FF4 Q41196139-315C866F-D6CF-409F-8DC7-13EEE89E6F80 Q42692593-6F430CFA-8AC1-4926-977B-502FDE12B0FB Q42718200-110EAC1B-3DC0-4144-A615-360D58DD2251 Q42730482-F35DB14F-33D6-46C7-B321-4CA38FB73726 Q42877746-0AAB449A-6135-4D00-ABDA-E84A2B1F9249 Q46350486-B0622D0E-77A1-47FE-8E4B-E7CCB0517869 Q46415696-AD9EDA58-1D80-4708-8058-0CB8DEA4F372 Q47160197-09914604-40F1-4C44-BDA8-9E58F4F6AAF3 Q47168388-C47A0485-A4E6-4A0A-8001-5A1CC4A1D3DB

P2860

Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions.

http://www.wikidata.org/entity/Q37333543

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Diabetes control and complicat ...... s: advances and contributions.

@en

Diabetes control and complicat ...... s: advances and contributions.

@nl

type

label

Diabetes control and complicat ...... s: advances and contributions.

@en

Diabetes control and complicat ...... s: advances and contributions.

@nl

prefLabel

Diabetes control and complicat ...... s: advances and contributions.

@en

Diabetes control and complicat ...... s: advances and contributions.

@nl

P1433

Q37333543-7B9A440F-84FD-4468-B6E3-16F87BAB62BE

P1476

Q37333543-8A0E316D-0498-4ED2-A226-ECD81A1FFA9C

P2093

Q37333543-088A0CFA-3B1C-4424-A79B-D006A694C183

Q37333543-0C0FBEB3-3123-4D9B-B8D9-F9DCD77F4319

Q37333543-2A9A22D2-FCA8-4200-A0A1-E8F2BE8A9B98

Q37333543-3BA28B59-3A85-47FF-B7CB-C124D876655B

Q37333543-3EB22B05-9571-46F5-ACFB-50101BA51B2E

Q37333543-97E4854A-762E-49B2-BAFD-3C438DCAA26F

Q37333543-CEED7CC6-C42B-40DE-911C-9692A13783A1

P2860

Q37333543-00280197-80AD-4169-B9A2-794C7E3BBD9A

Q37333543-060DDF71-2D3A-4C82-8C5B-196123A78B40

Q37333543-0662455D-FEDD-407B-94A5-F9AFAC698DF7

Q37333543-0F155E38-0093-4C3A-8A44-81E575E78BAD

Q37333543-1E1753C7-04BE-4A81-8B4C-77A558EFAF3A

Q37333543-227690F6-4EE3-439B-9A75-16247D5963AC

Q37333543-2DE400D6-93C6-4F61-8152-84D53718B123

Q37333543-2FB6C528-904C-4E94-904B-B1B2E6BD5401

Q37333543-3151580E-0E54-401F-9FAC-A6E31A01C9EC

Q37333543-39F8A6DA-2E62-4115-9C0C-7C88D4F04481

P304

Q37333543-957140BE-05D9-4B45-B3E0-F14D68276A66

P31

Q37333543-DF6E814E-5752-452F-9C9E-CF95D8A93C04

P356

Q37333543-1429E2D9-F794-47E2-8EAC-90FF852AB8BD

P407

Q37333543-3CB445D7-E1CF-425A-89C8-67743510FB9C

P433

Q37333543-8EA19F34-8BE6-44CB-B5D9-FC64D7ACC90E

P478

Q37333543-2C3DA22A-CDD1-4871-8315-61908D4DEB81

P50

Q37333543-1B681694-47B9-4BD1-B3E6-F81D375237B9

Q37333543-F1C9A00D-FA1B-4B7D-8038-F158A9BC6A52

P577

Q37333543-893965C2-BB00-4CE6-8E8E-BAF28C88C05F

P5875

Q37333543-C7089C15-819E-436F-B07A-C77882F98143

P698

Q37333543-6923EF22-EFE9-42D8-9037-8624912F9DAF

P921

Q37333543-2318BF04-A7DA-4C61-A056-0EB2BB60BE8E

P932

Q37333543-089E6EB2-3B17-4A47-904B-D4A628B08700

P356

P1433

P1476

Diabetes control and complicat ...... s: advances and contributions.

@en

P2093

DCCT/EDIC Research Group

http://www.w3.org/2001/XMLSchema#string

David M Nathan

http://www.w3.org/2001/XMLSchema#string

Gayle Lorenzi

http://www.w3.org/2001/XMLSchema#string

Margaret Bayless

http://www.w3.org/2001/XMLSchema#string

Patricia Cleary

http://www.w3.org/2001/XMLSchema#string

Rose Gubitosi-Klug

http://www.w3.org/2001/XMLSchema#string

Saul Genuth

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group

Pilot genome-wide association search identifies potential loci for risk of erectile dysfunction in type 1 diabetes using the DCCT/EDIC study cohort.

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline

Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents.

Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study

Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT S

Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (

P304

3976-3986

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB13-1093

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262045516

http://www.w3.org/2001/XMLSchema#string

P698

24264395

http://www.w3.org/2001/XMLSchema#string

P921

P932

3837056

http://www.w3.org/2001/XMLSchema#string